Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Parkinson's disease | R-HSA-1643685 | 0 | helveticoside | 441860 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | helveticoside | 441860 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | helveticoside | 441860 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | helveticoside | 441860 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | helveticoside | 441860 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | helveticoside | 441860 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | helveticoside | 441860 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | helveticoside | 441860 | drug-path |
| Taste transduction | R-HSA-162582 | map04742 | helveticoside | 441860 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | helveticoside | 441860 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | helveticoside | 441860 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | helveticoside | 441860 | drug-path |
| Thyroid cancer | R-HSA-9700206 | map05216 | helveticoside | 441860 | drug-path |
| Asthma | R-HSA-444620 | map05310 | helveticoside | 441860 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | helveticoside | 441860 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | helveticoside | 441860 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | helveticoside | 441860 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | helveticoside | 441860 | drug-path |
| Proteasome | R-HSA-68819 | map03050 | helveticoside | 441860 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | helveticoside | 441860 | drug-path |